Figures & data
Figure 2. (a) Observed survival based on the trial data and then predicted using hazard ratios. (b) Observed progression-free survival and then predicted using hazard ratios.
![Figure 2. (a) Observed survival based on the trial data and then predicted using hazard ratios. (b) Observed progression-free survival and then predicted using hazard ratios.](/cms/asset/f433275c-580c-49a7-8102-8811e90e4a7e/ilal_a_276958_f0002_b.jpg)
Table I. Calculation of costs of CVP
Table II. Rituximab cost calculation
Table III. R-CVP arm administration costs
Table IV. Salvage therapy regimens and costs over 6 months
Table V. Summary of base-case estimates, ranges for sensitivity analyses and quality of the evidence
Table VI. Base-case results